[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343782-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343782-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","oncologic-outcomes-of-screen-detected-and-non-screen-detected-t1-colorectal-cancers","Oncologic outcomes of screen-detected and non-screen-detected T1 colorectal cancers","","T1 colorectal cancer outcomes are assessed to determine whether results and risk models derived from non-screen-detected patients can be extrapolated to screen-detected cases. Multicenter data from 12 Dutch hospitals include 1,803 patients diagnosed during 2014–2017, with stage distribution and oncologic endpoints compared between groups. Lymph node metastasis at diagnosis is analyzed via multivariable logistic regression, and recurrence and survival are evaluated using Cox proportional hazards across TTR, MFS, CSS, and overall survival.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/oncologic-outcomes-of-screen-detected-and-non-screen-detected-t1-colorectal-cancers/343782/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/oncologic-outcomes-of-screen-detected-and-non-screen-detected-t1-colorectal-cancers/343782.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What study question addresses the difference between screen-detected and non-screen-detected T1 CRC?","Question",{"text":63,"@type":64},"Whether oncologic outcomes and risk models for T1 colorectal cancer based on non-screen-detected patients can be extrapolated to screen-detected T1 CRC.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were lymph node metastasis and risk factors analyzed in the study?",{"text":68,"@type":64},"Lymph node metastasis at diagnosis was compared using multivariable logistic regression, and conventional risk factors for lymph node metastasis were evaluated across groups.",{"name":70,"@type":61,"acceptedAnswer":71},"Which survival and recurrence endpoints were compared between the two groups?",{"text":72,"@type":64},"Time to recurrence, metastasis-free survival, cancer-specific survival, and overall survival were compared using Cox proportional hazard regression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343782,1790439116,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Oncologic outcomes of screen-detected and non-screen-detected  \nT1 colorectal cancers  \nGRAPHICAL ABSTRACT  \nStage distribution and oncologic outcomes of screen-detected T 1 CRC  \nMulticenter study  \n• Screen-detected vs.  \nnon-screen-detected T1 CRCs  \n• Diagnosed 2014–2017  \n• 1803 patients  \n– Scr1e2e. %detected:8191%14 (62%)  \nCRC, colorectal cancer OR, odds ratio  \nLNM, lymph node metastasis  \nLymph node metastasis in T1 CRCs  \nScreen detected  \nNonscreen detected  \n\n| \u003Cbr>12.6% | O\u003Cbr>(9 | R 1.49\u003Cbr>5%CI 0 | .89–2 | .30) |\n| --- | --- | --- | --- | --- |\n| \u003Cbr>8.9% |  |  |  |  |\n\n0% 10% 20% 30% 40% 50%  \nPerformance of a model with risk factors for LNM was comparable in the two groups  \nTime to recurrence  \nMetastasis-free survival Cancer-specific survival  \n5-year event-free,%  \n0% 20% 40% 60% 80% 100%  \n Screen detected  Non-screen detected  \nNo significant outcome difference  \nScreen-detected and non-screen-detected T1 CRC patients have similar stage distribution and oncologic outcomes   \nAuthors  \nLisa van der Schee1,2, Krijn J. C. Haasnoot1  , Sjoerd G. Elias3, Kim M. Gijsbers4,5, Yasser A. Alderlieste6, Yara Backes1, Anne-Marie van Berkel7, Femke Boersma8, Frank ter Borg5, Emilie C.H. Breekveldt9,10, Koen Kessels11  , Miriam Koopman12, Iris Lansdorp-Vogelaar9, Monique E. van Leerdam10,13, Gertjan Rasschaert14, Ramon-Michel Schreuder15, Ruud W.M. Schrauwen16, Tom C.J. Seerden14, Marcel B.W. Spanier17, Jochim S. Terhaar sive Droste18, Esther ToesZoutendijk9  , Jurriaan B. Tuynman19, Geraldine R. Vink12,20, Wouter H. de Vos tot Nederveen Cappel21, Frank P. Vleggaar1, Miangela M. Laclé2,‡, Leon M. G. Moons1,‡  \nInstitutions  \n1 Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, Netherlands  \n2 Pathology, University Medical Centre Utrecht, Utrecht, Netherlands  \n3 Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, Netherlands  \n4 Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, Netherlands  \n5 Gastroenterology and Hepatology, Deventer Hospital, Deventer, Netherlands  \n6 Gastroenterology and Hepatology, Beatrixziekenhuis, Gorinchem, Netherlands  \n7 Gastroenterology and Hepatology, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands  \n8 Gastroenterology and Hepatology, Gelre Hospitals, Apeldoorn, Netherlands  \n9 Public Health, Erasmus MC, Rotterdam, Netherlands  \n10 Gastrointestinal Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands  \n11 Gastroenterology and Hepatology, Sint Antonius Ziekenhuis, Nieuwegein, Netherlands  \n12 Medical Oncology, University Medical Centre Utrecht, Utrecht, Netherlands  \n13 Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands  \n14 Gastroenterology and Hepatology, Amphia Hospital, Breda, Netherlands  \n15 Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, Netherlands  \n16 Gastroenterology and Hepatology, Bernhoven Hospital Location Uden, Uden, Netherlands  \n17 Gastroenterology and Hepatology, Rijnstate Hospital Arnhem Branch, Arnhem, Netherlands  \n18 Gastroenterology and Hepatology, Jeroen Bosch Hospital, Den Bosch, Netherlands  \n‡ Contributed equally to this article  \n484 van der Schee Lisa et al. Oncologic outcomes of… Endoscopy 2024; 56: 484–493 | © 2024. The Author(s) .  \n19 Surgery, Amsterdam University Medical Centres, Amsterdam, Netherlands  \n20 Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands  \n21 Gastroenterology and Hepatology, Isala Hospital, Zwolle, Netherlands  \nreceived 9.8.2023  \naccepted after revision 5.2.2024 accepted manuscript online 7.2.2024 published online 13.3.2024  \nBibliography  \nEndoscopy 2024; 56: 484–493  \nDOI 10.1055/a-2263-2841  \nISSN 0013-726X  \n© 2024. The Author(s) .  \nThe Author(s) . This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribut","cbCaigJGWPyXThlv","https://ap.wps.com/l/cbCaigJGWPyXThlv","pdf",1086885,"English","# ABSTRACT\n## Background\n## Methods\n## Results","[{\"question\":\"What study question addresses the difference between screen-detected and non-screen-detected T1 CRC?\",\"answer\":\"Whether oncologic outcomes and risk models for T1 colorectal cancer based on non-screen-detected patients can be extrapolated to screen-detected T1 CRC.\"},{\"question\":\"How were lymph node metastasis and risk factors analyzed in the study?\",\"answer\":\"Lymph node metastasis at diagnosis was compared using multivariable logistic regression, and conventional risk factors for lymph node metastasis were evaluated across groups.\"},{\"question\":\"Which survival and recurrence endpoints were compared between the two groups?\",\"answer\":\"Time to recurrence, metastasis-free survival, cancer-specific survival, and overall survival were compared using Cox proportional hazard regression.\"}]","Oncologic outcomes of screen-detected and non-screen-detected T1 colorectal cancers | PDF",1790052090,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f0f46c2e20c95195b28e5a4e495fee8.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3aade23993c83167c2b8ae6efe4a6bdd.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eaac828349c4e0a8d091dfb051434ed5.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8043dcface6b4970d6d5cabbd1ec247.webp",980,1306]